Hypercholesterolemia in France, from recommendations to management in real life: The French gap

ConclusionThis study showed that hyper LDLemia is a common metabolic disease in France, affecting 23.3% of the population. The cholesterol-lowering prescriptions in France are very far from the recommendations for practice. Less than a third of the patients who would justify treatment are actually treated. This gap between the recommendations and real life corresponds to a real loss of opportunity for patients.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research